Stem cell therapy for central nervous system demyelinating disease

被引：14
|
作者：
Manganas L.N. [1 ]
Maletic-Savatic M. [1 ]
机构：
[1] Department of Neurology, Stony Brook University, Stony Brook
来源：
Current Neurology and Neuroscience Reports | 2005年 / 5卷 / 3期
关键词：
Multiple Sclerosis; Experimental Autoimmune Encephalomyelitis; Neural Stem Cell; Stem Cell Therapy; Bone Marrow Stem Cell;
D O I：
10.1007/s11910-005-0050-z
中图分类号：
学科分类号：
摘要：
Recent advances in cell-based therapies for demyelinating central nervous system diseases have demonstrated the ability to restore damaged neuronal architecture and function. Demyelinated axons in patients with multiple sclerosis can spontaneously remyelinate over time; however, the rate and extent at which remyelination occurs is inadequate for complete recovery. Previous attempts aimed at regenerating myelin-forming cells have been successful but limited by the multifocal nature of the lesions and the inability to produce large numbers of myelin-producing cells in culture. Stem cell-based therapy can overcome these limitations to some extent and may prove useful in the future treatment of demyelinating diseases. Copyright © 2005 by Current Science Inc.
引用
收藏
页码：225 / 231
页数：6
相关论文
共 50 条
  • [1] Gene therapy in autoimmune, demyelinating disease of the central nervous system
    Baker, D
    Hankey, DJR
    GENE THERAPY, 2003, 10 (10) : 844 - 853
  • [2] Gene therapy in autoimmune, demyelinating disease of the central nervous system
    David Baker
    D J R Hankey
    Gene Therapy, 2003, 10 : 844 - 853
  • [3] Intranasal delivery of stem cells as therapy for central nervous system disease
    Li, Yan-hua
    Feng, Ling
    Zhang, Guang-Xian
    Ma, Cun-gen
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 98 (02) : 145 - 151
  • [4] β7 integrins contribute to demyelinating disease of the central nervous system
    Kanwar, JR
    Harrison, JEB
    Wang, DM
    Leung, E
    Mueller, W
    Wagner, N
    Krissansen, GW
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 103 (02) : 146 - 152
  • [5] Rituximab therapy for ankylosing spondylitis associated to demyelinating disease of the central nervous system
    Heredia, Sergi
    Aparicio, Maria
    Armengol, Eulalia
    Juanola, Xavier
    JOINT BONE SPINE, 2016, 83 (01) : 105 - 106
  • [6] Biomarkers in Rare Demyelinating Disease of the Central Nervous System
    Boziki, Marina
    Sintila, Styliani-Aggeliki
    Ioannidis, Panagiotis
    Grigoriadis, Nikolaos
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 17
  • [7] Lyme Borreliosis and Demyelinating Disease of the Central Nervous System
    Bazovska, S.
    Durovska, J.
    Pancak, J.
    Zaborska, M.
    Derdakova, M.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2011, 60 (01): : 45 - 47
  • [8] Helicobacter pylori infection and demyelinating disease of the central nervous system
    Kira, Jun-ichi
    Isobe, Noriko
    JOURNAL OF NEUROIMMUNOLOGY, 2019, 329 : 14 - 19
  • [9] Citation classics in central nervous system inflammatory demyelinating disease
    Kim, Jee-Eun
    Park, Kang M.
    Kim, Yerim
    Yoon, Dae Y.
    Bae, Jong S.
    BRAIN AND BEHAVIOR, 2017, 7 (06):
  • [10] Demyelinating disease affecting both central and peripheral nervous system
    Carra-Dalliere, C.
    Mania, A.
    Carlander, B.
    Camu, W.
    Juntas-Morales, R.
    REVUE NEUROLOGIQUE, 2011, 167 (12) : 921 - 925
12345